Expert Insight How Are You and Your Peers Navigating Pharma Manufacturing in 2026? [Survey] 5 February 2026
Expert Insight China’s Biotech Ascent Reshapes Global Pharma Strategy, Dominates JPM26 Discussions 19 January 2026
Expert Insight State of Cell & Gene Therapy 2026: Cautious Optimism as Investment Rises 19 January 2026
Expert Insight Novo Nordisk CEO: We Were ‘Cursed as a Leader’ as Lilly Closes GLP-1 Gap 19 January 2026
Expert Insight FDA Veteran Pazdur Warns Industry Cites ‘Chaos’ at JPM Healthcare Conference 2026 19 January 2026
Expert Insight The New Manufacturing Reality for 2026: The Rise of Radiopharma, Industrialization, and Investment Pressure 19 January 2026
Expert Insight Radiopharmaceutical manufacturing: Why headline capacity breaks down under half-life constraints 19 January 2026